Related Experiment Video

Updated: Oct 17, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity

T Nakashima1, M Miura, M Hara

  • 1Drug Discovery Research Laboratories, Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.

Cancer Research
|March 23, 2000
PubMed

Insights

Tetrocarcin A (TC-A) inhibits the anti-apoptotic protein Bcl-2, restoring programmed cell death (apoptosis) in cancer cells. This microbial metabolite targets Bcl-2

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Bcl-2 is an intracellular membrane protein that inhibits apoptosis, a crucial process in cell death pathways.
  • Overexpression of Bcl-2 prevents apoptosis, contributing to diseases like cancer.
  • Caspase-3 is a key effector in mammalian cell death pathways, and Bcl-2 negatively regulates its activation.

Purpose of the Study:

  • To identify inhibitors of the anti-apoptotic function of Bcl-2.
  • To investigate the potential of Tetrocarcin A (TC-A) as a Bcl-2 inhibitor.
  • To explore TC-A's mechanism of action and its potential as a pharmacological target.

Main Methods:

  • Utilized cell lines overexpressing Bcl-2 or Bcl-XL.
  • Treated cells with various apoptosis-inducing agents (anti-Fas antibody, TNF-alpha, staurosporine, Bax) in combination with TC-A.
  • Assessed apoptosis induction and mitochondrial function changes (transmembrane potential, cytochrome c release).

Main Results:

  • Tetrocarcin A (TC-A) was identified as an inhibitor of Bcl-2's anti-apoptotic function.
  • TC-A induced apoptosis in Bcl-2-overexpressing cells treated with apoptosis-inducing agents.
  • TC-A selectively targeted pro-apoptotic Bcl-2 family members and inhibited Bcl-2-regulated mitochondrial functions.

Conclusions:

  • Tetrocarcin A (TC-A) effectively reverses the anti-apoptotic effect of Bcl-2 by inhibiting its mitochondrial functions.
  • TC-A serves as a potential therapeutic agent and a model for developing specific Bcl-2 inhibitors.
  • Targeting Bcl-2's mitochondrial functions presents a promising strategy for cancer therapy.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...